Published in Rheumatol Int on May 29, 2010
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int (2010) 1.68
Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study. J Bone Miner Res (2015) 1.50
High-resolution computed tomography for clinical imaging of bone microarchitecture. Clin Orthop Relat Res (2011) 1.32
Atypical fractures do not have a thicker cortex. Osteoporos Int (2012) 1.17
High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep (2013) 1.11
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporos Int (2011) 1.03
Quantitative characterization of subject motion in HR-pQCT images of the distal radius and tibia. Bone (2011) 0.98
Noninvasive imaging of bone microarchitecture. Ann N Y Acad Sci (2011) 0.98
New laboratory tools in the assessment of bone quality. Osteoporos Int (2011) 0.98
A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis (2013) 0.97
Clinical imaging of bone microarchitecture with HR-pQCT. Curr Osteoporos Rep (2013) 0.94
Possible benefits of strontium ranelate in complicated long bone fractures. Rheumatol Int (2010) 0.92
Recent progress in bone imaging for osteoporosis research. J Bone Miner Metab (2011) 0.91
Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women. Bone (2010) 0.90
Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment. Springerplus (2014) 0.90
Strontium ranelate: in search for the mechanism of action. J Bone Miner Metab (2013) 0.87
In vivo bone architecture in pompe disease using high-resolution peripheral computed tomography. JIMD Rep (2012) 0.85
Goal-directed treatment of osteoporosis in Europe. Osteoporos Int (2014) 0.84
Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy. BMC Res Notes (2013) 0.75
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses. Bonekey Rep (2016) 0.75
Sr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate. PLoS One (2017) 0.75
Normalization of bone mineral density after five years of treatment with strontium ranelate. Clin Cases Miner Bone Metab (2015) 0.75
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med (2006) 7.45
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med (2004) 6.55
In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab (2005) 5.31
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest (1983) 4.53
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
In vivo high resolution 3D-QCT of the human forearm. Technol Health Care (1998) 3.49
Treatment of postmenopausal osteoporosis. Lancet (2002) 3.37
Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab (1994) 2.39
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest (1997) 2.33
Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone (2007) 2.33
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone (2000) 2.24
Ridge number density: a new parameter for in vivo bone structure analysis. Bone (1997) 2.03
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest (1993) 1.84
Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res (2005) 1.57
Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone (2007) 1.52
Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res (2008) 1.51
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporos Int (2008) 1.39
Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol (2009) 1.30
The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol (2007) 1.23
The effects of geometric and threshold definitions on cortical bone metrics assessed by in vivo high-resolution peripheral quantitative computed tomography. Calcif Tissue Int (2007) 1.14
Bisphosphonates: how do they work? Best Pract Res Clin Endocrinol Metab (2008) 1.07
In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. Osteoporos Int (2009) 1.07
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int (2008) 0.98
Trabecular bone microarchitecture after alendronate treatment of osteoporotic women. Curr Med Res Opin (2005) 0.97
The mineralization of bone tissue: a forgotten dimension in osteoporosis research. Osteoporos Int (2003) 0.95
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med (2009) 13.57
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res (2004) 4.04
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum (2006) 2.82
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res (2012) 2.34
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res (2011) 2.24
Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom (2008) 2.21
Assessment of the 10-year probability of osteoporotic hip fracture combining clinical risk factors and heel bone ultrasound: the EPISEM prospective cohort of 12,958 elderly women. J Bone Miner Res (2008) 2.20
The perspective of the international osteoporosis foundation on the official positions of the international society for clinical densitometry. J Clin Densitom (2005) 2.14
High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res (2008) 2.04
Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res (2004) 2.01
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine (2012) 1.85
Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol (2005) 1.84
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res (2005) 1.81
Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom (2011) 1.77
Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Bone (2005) 1.65
Contribution of clinical tests to the diagnosis of rotator cuff disease: a systematic literature review. Joint Bone Spine (2008) 1.65
Risedronate prevents new vertebral fractures in postmenopausal women at high risk. J Clin Endocrinol Metab (2003) 1.65
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc (2010) 1.62
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab (2013) 1.60
A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis. Joint Bone Spine (2014) 1.54
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry. Osteoporos Int (2005) 1.51
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc (2004) 1.44
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone (2008) 1.44
Male osteoporosis: diagnosis and fracture risk evaluation. Joint Bone Spine (2009) 1.40
Functional hypoparathyroidism in postmenopausal women with fragility fracture. Joint Bone Spine (2011) 1.39
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res (2005) 1.39
Acute changes in neuromuscular excitability after exhaustive whole body vibration exercise as compared to exhaustion by squatting exercise. Clin Physiol Funct Imaging (2003) 1.39
Vascular adaptation to deconditioning and the effect of an exercise countermeasure: results of the Berlin Bed Rest study. J Appl Physiol (1985) (2005) 1.36
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol (2005) 1.29
Is muscle power output a key factor in the age-related decline in physical performance? A comparison of muscle cross section, chair-rising test and jumping power. Clin Physiol Funct Imaging (2004) 1.28
Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin (2004) 1.28
Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int (2008) 1.26
Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res (2004) 1.26
When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2004) 1.24
Treatment of chronic lower back pain with lumbar extension and whole-body vibration exercise: a randomized controlled trial. Spine (Phila Pa 1976) (2002) 1.23
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. Clin Interv Aging (2008) 1.22
Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab (2010) 1.21
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol (2008) 1.18
Impact of bed rest on conduit artery remodeling: effect of exercise countermeasures. Hypertension (2010) 1.17
Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol (2007) 1.17
Tail suspension induces bone loss in skeletally mature mice in the C57BL/6J strain but not in the C3H/HeJ strain. J Bone Miner Res (2003) 1.17
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res (2005) 1.16
Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom (2009) 1.14
Reproducibility of the jumping mechanography as a test of mechanical power output in physically competent adult and elderly subjects. J Am Geriatr Soc (2004) 1.11
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone (2013) 1.05
Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. Endocrinology (2005) 1.03
Long term bed rest with and without vibration exercise countermeasures: effects on human muscle protein dysregulation. Proteomics (2010) 1.02
Obstructive sleep apnea is associated with preserved bone mineral density in healthy elderly subjects. Sleep (2013) 1.01
How long should patients take medications for postmenopausal osteoporosis? Joint Bone Spine (2006) 1.01
Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology (2007) 1.00
Ryanodine receptor type-1 (RyR1) expression and protein S-nitrosylation pattern in human soleus myofibres following bed rest and exercise countermeasure. Histochem Cell Biol (2008) 1.00
WISE-2005: bed-rest induced changes in bone mineral density in women during 60 days simulated microgravity. Bone (2011) 1.00
Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res (2010) 0.99
Prevalence and antimicrobial resistance of Campylobacter coli isolated from fattening pigs in France. Vet Microbiol (2004) 0.99
Countermeasures against lumbar spine deconditioning in prolonged bed rest: resistive exercise with and without whole body vibration. J Appl Physiol (1985) (2010) 0.99
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Curr Med Res Opin (2006) 0.99
Differential atrophy of the lower-limb musculature during prolonged bed-rest. Eur J Appl Physiol (2009) 0.99
Human skeletal muscle structure and function preserved by vibration muscle exercise following 55 days of bed rest. Eur J Appl Physiol (2006) 0.97
Anatomic variations of the arteries of the nasal fossa. Otolaryngol Head Neck Surg (2003) 0.97
Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise. Bone (2009) 0.96
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2011) 0.96
Infectious sacroiliitis: a retrospective, multicentre study of 39 adults. BMC Infect Dis (2012) 0.96
Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone (2006) 0.95
Clinical factors associated with trabecular bone score. J Clin Densitom (2013) 0.95
Low estimates of dietary acid load are positively associated with bone ultrasound in women older than 75 years of age with a lifetime fracture. J Nutr (2008) 0.95
Radiologic assessment of age-related knee joint space changes in women: a 4-year longitudinal study. Arthritis Rheum (2009) 0.95
Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom (2008) 0.94
Constitutional thinness: unusual human phenotype of low bone quality. J Clin Endocrinol Metab (2007) 0.93
Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women. J Bone Miner Res (2014) 0.93
Trabecular and cortical bone density and architecture in women after 60 days of bed rest using high-resolution pQCT: WISE 2005. J Bone Miner Res (2011) 0.93
No influence of age, gender, weight, height, and impact profile in achilles tendinopathy in masters track and field athletes. Am J Sports Med (2009) 0.92
Impaired energetic metabolism after central leptin signaling leads to massive appendicular bone loss in hindlimb-suspended rats. J Bone Miner Res (2008) 0.92
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Curr Med Res Opin (2003) 0.92
Muscle atrophy and changes in spinal morphology: is the lumbar spine vulnerable after prolonged bed-rest? Spine (Phila Pa 1976) (2011) 0.92
Heterogeneous atrophy occurs within individual lower limb muscles during 60 days of bed rest. J Appl Physiol (1985) (2012) 0.92
Changes in intervertebral disc morphology persist 5 mo after 21-day bed rest. J Appl Physiol (1985) (2011) 0.91
Magnetic resonance imaging assessment of trunk muscles during prolonged bed rest. Spine (Phila Pa 1976) (2007) 0.91
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab (2009) 0.91
Quantitative ultrasound for the detection and management of osteoporosis. Salud Publica Mex (2009) 0.90
The Chinese in Canada: a study in ethnic change with emphasis on gender roles. J Soc Psychol (2004) 0.90
Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy. J Cancer Res Clin Oncol (2009) 0.90
Leptin increases proliferation of human steosarcoma cells through activation of PI(3)-K and MAPK pathways. Med Sci Monit (2006) 0.90
The effects of rehabilitation on the muscles of the trunk following prolonged bed rest. Eur Spine J (2010) 0.89
Different cellular fatty acid pattern behaviours of two strains of Listeria monocytogenes Scott A and CNL 895807 under different temperature and salinity conditions. FEMS Microbiol Lett (2003) 0.89
Bed rest and cognition: effects on executive functioning and reaction time. Aviat Space Environ Med (2009) 0.88
Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate. J Clin Densitom (2008) 0.88
Devising global strategies for fracture-risk evaluation. Joint Bone Spine (2007) 0.87
Influenza A(H1N1)pdm09 virus in pigs, Réunion Island. Emerg Infect Dis (2012) 0.86